Japan Medical Dynamic Marketing,INC. [7600.T]

TOKYO, May 08 (Pulse News Wire) – Japan Medical Dynamic Marketing,inc. (7600.T) reported its fiscal year 2026 earnings forecast fell short of expectations due to lower-than-projected revenue.

For the fiscal year ending March 31, 2026, the company's revenue was estimated at ¥24.80 billion compared to the previous forecast of __NUM_0__. Operating profit came in at ¥574 million versus the earlier projection of ¥700 million. Similarly, net income attributable to shareholders dropped to ¥263 million from the previously anticipated ¥300 million.

The shortfall was attributed to reduced patient cases in Japan amid media reports and decreased knee replacement acquisitions in the US. Despite efforts to streamline sales and administrative expenses, manufacturing costs increased due to higher labor fees associated with product supply adjustments. In light of these factors, along with more conservative estimates for deferred tax asset recoverability, the company decided to maintain its annual dividend payout of ¥17 per share, citing stable future performance forecasts and robust financial health.

Due to extended review processes related to deferred tax assets, the release of the interim report was delayed from April 30, 2026 to May 08, 2026.

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.